Human Phenotype Ontology 
Grandparent Node:
expand
Abnormal circulating carboxylic acid concentration (HP:0004354)help
Parent Node:
expand
Abnormality of amino acid metabolism (HP:0004337)help
..Starting node
..expand
Abnormal circulating aromatic amino acid concentration (HP:0004338)help
Term ID: 4338
Name: Abnormal circulating aromatic amino acid concentration
Synonym: Abnormality of aromatic amino acid family metabolism
Definition: Any deviation from the normal concentration of a aromatic amino acid in the blood circulation.
Comments:
Reference: HP:0004338
Genes and Diseases:
 
       Child Nodes:
........expandAbnormality of tryptophan metabolism (HP:0004365) help
................... HP:0003361 Tryptophanuria
........expandAbnormality of phenylalanine metabolism (HP:0010893) help
................... HP:0003612 Positive ferric chloride test
................... HP:0004922 Atypical hyperphenylalaninemia
................... HP:0004923 Hyperphenylalaninemia
................... HP:0005982 Reduced phenylalanine hydroxylase activity
................... HP:0008297 Transient hyperphenylalaninemia
................... HP:0100610 Maternal hyperphenylalaninemia
........expandAbnormality of tyrosine metabolism (HP:0010917) help
................... HP:0003231 Hypertyrosinemia

 Sister Nodes: 
..expandAbnormal circulating amino acid concentration (HP:0003112) help
..expandAbnormal circulating aspartate family amino acid concentration (HP:0010899) help
..expandAbnormal circulating branched chain amino acid concentration (HP:0010892) help
..expandAbnormal circulating citrulline concentration (HP:0011965) help
..expandAbnormal circulating creatine concentration (HP:0012113) help
..expandAbnormal circulating glutamine family amino acid concentration (HP:0010902) help
..expandAbnormal circulating histidine concentration (HP:0010904) help
..expandAbnormal circulating ornithine concentration (HP:0012025) help
..expandAbnormal circulating pyruvate family amino acid concentration (HP:0010915) help
..expandAbnormal circulating sulfur amino acid concentration (HP:0004339) help
..expandAminoaciduria (HP:0003355) help
..expandHyperbeta-alaninemia (HP:0012556) help
..expandPropionyl-CoA carboxylase deficiency (HP:0003353) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0004338HP:0004338Abnormal circulating aromatic amino acid concentration0BCS1L CL E G H6171020OMIM:124000Mitochondrial complex III deficiency, nuclear type 172
HP:0004338HP:0004338Abnormal circulating aromatic amino acid concentration0FAH CL E G H21843579OMIM:276700Tyrosinemia, type I107
HP:0004338HP:0004338Abnormal circulating aromatic amino acid concentration0FTCD CL E G H108413974OMIM:229100Formiminotransferase deficiency65
HP:0004338HP:0004338Abnormal circulating aromatic amino acid concentration0GCH1 CL E G H26434193ORPHA:98808Autosomal dominant dopa-responsive dystonia86
HP:0004338HP:0004338Abnormal circulating aromatic amino acid concentration0GCH1 CL E G H26434193OMIM:128230Dystonia, DOPA-responsive, with or without hyperphenylalaninemia86
HP:0004338HP:0004338Abnormal circulating aromatic amino acid concentration0GCH1 CL E G H26434193OMIM:233910Hyperphenylalaninemia, BH4-deficient, B86
HP:0004338HP:0004338Abnormal circulating aromatic amino acid concentration0HPD CL E G H32425147ORPHA:2118Hawkinsinuria23
HP:0004338HP:0004338Abnormal circulating aromatic amino acid concentration0HPD CL E G H32425147OMIM:140350HAWKINSINURIA23
HP:0004338HP:0004338Abnormal circulating aromatic amino acid concentration0HPD CL E G H32425147OMIM:276710Tyrosinemia, type III23
HP:0004338HP:0004338Abnormal circulating aromatic amino acid concentration0IMPDH2 CL E G H36156053ORPHA:98808Autosomal dominant dopa-responsive dystonia1
HP:0004338HP:0004338Abnormal circulating aromatic amino acid concentration0KYNU CL E G H89426469ORPHA:79155Hydroxykynureninuria5
HP:0004338HP:0004338Abnormal circulating aromatic amino acid concentration0NR4A2 CL E G H49297981ORPHA:98808Autosomal dominant dopa-responsive dystonia27
HP:0004338HP:0004338Abnormal circulating aromatic amino acid concentration0PAH CL E G H50538582ORPHA:79254Classic phenylketonuria641
HP:0004338HP:0004338Abnormal circulating aromatic amino acid concentration0PCBD1 CL E G H50928646OMIM:264070Hyperphenylalaninemia, BH4-deficient, D24
HP:0004338HP:0004338Abnormal circulating aromatic amino acid concentration0PCBD1 CL E G H50928646ORPHA:1578Pterin-4 alpha-carbinolamine dehydratase deficiency24
HP:0004338HP:0004338Abnormal circulating aromatic amino acid concentration0PNPO CL E G H5516330260ORPHA:79096Pyridoxal phosphate-responsive seizures92
HP:0004338HP:0004338Abnormal circulating aromatic amino acid concentration0PTS CL E G H58059689OMIM:261640Hyperphenylalaninemia, BH4-deficient, A19
HP:0004338HP:0004338Abnormal circulating aromatic amino acid concentration0QDPR CL E G H58609752OMIM:261630Hyperphenylalaninemia, bh4-deficient, C43
HP:0004338HP:0004338Abnormal circulating aromatic amino acid concentration0SLC25A13 CL E G H1016510983ORPHA:247598Neonatal intrahepatic cholestasis due to citrin deficiency82
HP:0004338HP:0004338Abnormal circulating aromatic amino acid concentration0SPR CL E G H669711257OMIM:612716Dystonia, dopa-responsive, due to sepiapterin reductase deficiency28
HP:0004338HP:0004338Abnormal circulating aromatic amino acid concentration0TAT CL E G H689811573OMIM:276600Tyrosine transaminase deficiency43
HP:0004338HP:0010917Abnormal circulating tyrosine concentration1BCS1L CL E G H6171020OMIM:124000Mitochondrial complex III deficiency, nuclear type 172
HP:0004338HP:0010917Abnormal circulating tyrosine concentration1FAH CL E G H21843579OMIM:276700Tyrosinemia, type I107
HP:0004338HP:0010893Abnormal circulating phenylalanine concentration1FTCD CL E G H108413974OMIM:229100Formiminotransferase deficiency65
HP:0004338HP:0010893Abnormal circulating phenylalanine concentration1GCH1 CL E G H26434193ORPHA:98808Autosomal dominant dopa-responsive dystonia86
HP:0004338HP:0010893Abnormal circulating phenylalanine concentration1GCH1 CL E G H26434193OMIM:128230Dystonia, DOPA-responsive, with or without hyperphenylalaninemia86
HP:0004338HP:0010893Abnormal circulating phenylalanine concentration1GCH1 CL E G H26434193OMIM:233910Hyperphenylalaninemia, BH4-deficient, B86
HP:0004338HP:0010917Abnormal circulating tyrosine concentration1HPD CL E G H32425147ORPHA:2118HawkinsinuriaHP:0040281 - Very frequent23
HP:0004338HP:0010917Abnormal circulating tyrosine concentration1HPD CL E G H32425147OMIM:140350HAWKINSINURIA23
HP:0004338HP:0010917Abnormal circulating tyrosine concentration1HPD CL E G H32425147OMIM:276710Tyrosinemia, type III23
HP:0004338HP:0010893Abnormal circulating phenylalanine concentration1IMPDH2 CL E G H36156053ORPHA:98808Autosomal dominant dopa-responsive dystonia1
HP:0004338HP:0004365Abnormal circulating tryptophan concentration1KYNU CL E G H89426469ORPHA:79155HydroxykynureninuriaHP:0040280 - Obligate5
HP:0004338HP:0010893Abnormal circulating phenylalanine concentration1NR4A2 CL E G H49297981ORPHA:98808Autosomal dominant dopa-responsive dystonia27
HP:0004338HP:0010893Abnormal circulating phenylalanine concentration1PAH CL E G H50538582ORPHA:79254Classic phenylketonuria641
HP:0004338HP:0010893Abnormal circulating phenylalanine concentration1PCBD1 CL E G H50928646OMIM:264070Hyperphenylalaninemia, BH4-deficient, D24
HP:0004338HP:0010893Abnormal circulating phenylalanine concentration1PCBD1 CL E G H50928646ORPHA:1578Pterin-4 alpha-carbinolamine dehydratase deficiency24
HP:0004338HP:0010917Abnormal circulating tyrosine concentration1PNPO CL E G H5516330260ORPHA:79096Pyridoxal phosphate-responsive seizuresHP:0040283 - Occasional92
HP:0004338HP:0010893Abnormal circulating phenylalanine concentration1PTS CL E G H58059689OMIM:261640Hyperphenylalaninemia, BH4-deficient, A19
HP:0004338HP:0010893Abnormal circulating phenylalanine concentration1QDPR CL E G H58609752OMIM:261630Hyperphenylalaninemia, bh4-deficient, C43
HP:0004338HP:0010917Abnormal circulating tyrosine concentration1SLC25A13 CL E G H1016510983ORPHA:247598Neonatal intrahepatic cholestasis due to citrin deficiency82
HP:0004338HP:0010893Abnormal circulating phenylalanine concentration1SPR CL E G H669711257OMIM:612716Dystonia, dopa-responsive, due to sepiapterin reductase deficiency28
HP:0004338HP:0010917Abnormal circulating tyrosine concentration1TAT CL E G H689811573OMIM:276600Tyrosine transaminase deficiency43
HP:0004338HP:0500141Hypophenylalaninemia2 CL E G H
HP:0004338HP:0500135Hypotryptophanemia2 CL E G H
HP:0004338HP:0500134Hypertryptophanemia2 CL E G H
HP:0004338HP:0500133Hypotyrosinemia2 CL E G H
HP:0004338HP:0100610Maternal hyperphenylalaninemia2 CL E G H
HP:0004338HP:0004922Atypical hyperphenylalaninemia2 CL E G H
HP:0004338HP:0003231Hypertyrosinemia2BCS1L CL E G H6171020OMIM:124000Mitochondrial complex III deficiency, nuclear type 172
HP:0004338HP:0003231Hypertyrosinemia2FAH CL E G H21843579OMIM:276700Tyrosinemia, type I.107
HP:0004338HP:0003612Positive ferric chloride test2FTCD CL E G H108413974OMIM:229100Formiminotransferase deficiency.65
HP:0004338HP:0008297Transient hyperphenylalaninemia2GCH1 CL E G H26434193ORPHA:98808Autosomal dominant dopa-responsive dystoniaHP:0040282 - Frequent86
HP:0004338HP:0008297Transient hyperphenylalaninemia2GCH1 CL E G H26434193OMIM:128230Dystonia, DOPA-responsive, with or without hyperphenylalaninemia.86
HP:0004338HP:0004923Hyperphenylalaninemia2GCH1 CL E G H26434193OMIM:233910Hyperphenylalaninemia, BH4-deficient, B.86
HP:0004338HP:0003231Hypertyrosinemia2HPD CL E G H32425147OMIM:140350HAWKINSINURIA.23
HP:0004338HP:0003231Hypertyrosinemia2HPD CL E G H32425147OMIM:276710Tyrosinemia, type III.23
HP:0004338HP:0008297Transient hyperphenylalaninemia2IMPDH2 CL E G H36156053ORPHA:98808Autosomal dominant dopa-responsive dystoniaHP:0040282 - Frequent1
HP:0004338HP:0008297Transient hyperphenylalaninemia2NR4A2 CL E G H49297981ORPHA:98808Autosomal dominant dopa-responsive dystoniaHP:0040282 - Frequent27
HP:0004338HP:0004923Hyperphenylalaninemia2PAH CL E G H50538582ORPHA:79254Classic phenylketonuriaHP:0040281 - Very frequent641
HP:0004338HP:0008297Transient hyperphenylalaninemia2PCBD1 CL E G H50928646OMIM:264070Hyperphenylalaninemia, BH4-deficient, D24
HP:0004338HP:0004923Hyperphenylalaninemia2PCBD1 CL E G H50928646OMIM:264070Hyperphenylalaninemia, BH4-deficient, D24
HP:0004338HP:0004923Hyperphenylalaninemia2PCBD1 CL E G H50928646ORPHA:1578Pterin-4 alpha-carbinolamine dehydratase deficiencyHP:0040281 - Very frequent24
HP:0004338HP:0004923Hyperphenylalaninemia2PTS CL E G H58059689OMIM:261640Hyperphenylalaninemia, BH4-deficient, A.19
HP:0004338HP:0004923Hyperphenylalaninemia2QDPR CL E G H58609752OMIM:261630Hyperphenylalaninemia, bh4-deficient, C.43
HP:0004338HP:0003231Hypertyrosinemia2SLC25A13 CL E G H1016510983ORPHA:247598Neonatal intrahepatic cholestasis due to citrin deficiencyHP:0040282 - Frequent82
HP:0004338HP:0008297Transient hyperphenylalaninemia2SPR CL E G H669711257OMIM:612716Dystonia, dopa-responsive, due to sepiapterin reductase deficiency.28
HP:0004338HP:0003231Hypertyrosinemia2TAT CL E G H689811573OMIM:276600Tyrosine transaminase deficiency.43


Genes (16) :BCS1L FAH FTCD GCH1 HPD IMPDH2 KYNU NR4A2 PAH PCBD1 PNPO PTS QDPR SLC25A13 SPR TAT

Diseases (19) :OMIM:124000 OMIM:276700 OMIM:229100 ORPHA:98808 OMIM:128230 OMIM:233910 ORPHA:2118 OMIM:140350 OMIM:276710 ORPHA:79155 ORPHA:79254 OMIM:264070 ORPHA:1578 ORPHA:79096 OMIM:261640 OMIM:261630 ORPHA:247598 OMIM:612716 OMIM:276600
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.